ClinicalTrials.govpublic full text
A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Immunogenicity of Test Pertuzumab (ZRC-3277, Cadila Healthcare Ltd.,)
metastatic breast cancer, her2 positive, pertuzumab, breast cancer, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 873255
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.